CDMO SK Pharmteco has completed two advanced manufacturing facilities at its production campus in Swords, Ireland, significantly expanding its pharmaceutical ingredient capabilities. The company first announced plans for a phased expansion at
Tom Goldstein, the founder of SCOTUSBlog, is scheduled to be sentenced today in a case that has drawn significant attention across the legal community. In a development that reads more like a
MoreRELX PLC (LSE:REL) is beginning to silence its critics by demonstrating that artificial intelligence could accelerate growth rather than undermine its core business model. Following strong first-half results from the FTSE 100
MoreThe US stock market has shown tentative signs of stabilisation in recent sessions, with investors cautiously debating whether the worst of the recent selloff is over. For contrarian investors willing to bet
MoreIndia-based active pharmaceutical ingredient makers Jagsonpal Pharmaceuticals and Tyche Industries have each received warning letters from the US Food and Drug Administration. Both companies were also placed on the FDA’s import alert
MoreOn July 13, the OCC, FDIC, and NCUA issued interagency guidance addressing how banks should approach lending to individuals not legally authorised to work in the United States. The guidance was issued
MoreHSBC Holdings PLC (LSE:HSBA) has agreed to sell its Singapore life and health insurance business to Germany’s Allianz for US$2.1 billion, equivalent to approximately £1.6 billion. The transaction forms part of the
MoreThe United States has imposed sweeping new tariffs on 60 economies, citing their failure to enforce bans on goods produced using forced labour. The Office of the U.S. Trade Representative acted under
MoreBeOne Medicines is investing $300 million into its flagship New Jersey campus to expand domestic drug manufacturing with new small molecule production capabilities. The investment targets the company’s Princeton West Innovation Campus
MoreCompanies selecting AI models in 2026 face a regulatory minefield that is at least as complex as any technical capability comparison between competing systems. At the G7 summit in June, French President
MoreTodd Blanche, nominee for Attorney General, is facing accusations from senior senators that he privately admitted creating a $1.8 billion DOJ fund was a mistake and then denied it in writing. The
More
